-
Abstract Number: PB1186
A Bypass Surgery with Congenital Factor 5 and Factor 8 Deficiency
-
Abstract Number: PB0905
A Canadian, Multi-Center, Retrospective, Non-Interventional Study of Clinical Outcomes from Early Use of N9-GP Compared with Previous Treatment in Patients with Hemophilia B in a Real-World Setting
-
Abstract Number: PB0008
A Case Report of a Patient with Hereditary Angioedema and Samter´s Syndrome Treated with Anticoagulant of Direct Action Anti Xa (Rivaroxaban), Secondary to Angioplasty due to Ischemic Heart Disease
-
Abstract Number: PB2454
A Case Report of Deep Vein Thrombosis after Kidney Transplantation
-
Abstract Number: PB0711
A Case Report of Spontaneous and Recurrent Arterial and Venous Thrombotic Events in a Child with FGA c.1372C>T Mutation
-
Abstract Number: PB1432
A Challenging Case of Delayed-onset Refractory Heparin-induced Thrombocytopenia Complicated with Arterial Thrombosis
-
Abstract Number: PB1305
A Child with Ischemia of the Glans Penis after Circumcision
-
Abstract Number: PB1609
A Close Relationship between Adipocytes and Megakaryocytes
-
Abstract Number: PB2283
A Combination of Age Adjusted Cut-Off and Preanalytical Conditions Monitoring for Increased DDIM Assay Specificity
-
Abstract Number: PB0856
A Comparative Analysis of the Immune Response to Homologous Coagulation Factors V and VIII
-
Abstract Number: PB0201
A Comparison of Mass and Potency Equated Bovine and Porcine Heparins
-
Abstract Number: PB0670
A Correlation of Thrombin Generation Assay and Clot Waveform Analysis in Patients on Warfarin
-
Abstract Number: PB0248
A Critical Role of Carboxyl-Terminal Alpha-Helix in the Secretion of Coagulation Factor XI
-
Abstract Number: PB2335
A Decade of Experience in Peripherally Inserted Central Catheter (PICC) Related Thrombosis in Hematological Malignancies of a Single Spanish Center
-
Abstract Number: PB1075
A Descriptive Study of Physical Activity and Fitness Level Profiles of Nigerians with Haemophila
-
Abstract Number: PB1196
A Digestive Hemorrhage Like No Other
-
Abstract Number: PB0189
A Double Heterozygous Factor VII (FVII) Deficiency: Exon 9 Missense Mutation (Arg364Gln – FVII Padua) and a Novel Exon 3 Missense Mutation (Ala87Gly)
-
Abstract Number: PB0889
A French Multicentre Prospective, Non-Interventional Study (B-SURE) Evaluating Real-World Usage and Effectiveness of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in People with Haemophilia B: Baseline Data
-
Abstract Number: PB0859
A Generic Recombinant Factor VIIa Is Comparable to the Branded Novoseven in In-vitro and Pharmacokinetic Studies in Primates
-
Abstract Number: PB0732
A Genetic Modifier of Venous Thrombosis in Zebrafish Reveals a Functional Role for Fibrinogen AαE in Early Hemostasis
-
Abstract Number: PB0393
A Hereditary Bleeding Disorder Caused by a Novel Homozygous Mutation of Thrombomodulin Gene
-
Abstract Number: PB1731
A Humanised CLEC-2 Mouse Model to Study Anti-Human CLEC-2 Biologics in vivo
-
Abstract Number: PB1365
A Long Term Survival Chronic DIC with ITP Treated with Low Dose Steroid
-
Abstract Number: PB/CO05
A Low Dose Heparin Protocol Is Associated with Improved Duration of Arterial Line Patency in Critically Ill COVID-19 Patients
-
Abstract Number: PB0414
A Membrane-Adjacent Region in Tissue Factor Provides Substrate Selectivity
-
Abstract Number: PB1229
A Multi Centre Non-randomised Clinical Trial to Establish the Efficacy of Peer Reviewed Physiotherapy Treatment Protocols among PWH in India
-
Abstract Number: PB0295
A Multicenter Experience with Idarucizumab “In Real World” as Reversal Anticoagulation of Dabigatran
-
Abstract Number: PB1034
A Multicenter Open-label Single Arm Trial to Evaluate Safety and Efficacy and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (SCT800) in Previously Treated Patients with Severe Hemophilia A under Prophylaxis Therapy
-
Abstract Number: PB0802
A Multicenter Prospective Validation Study on Disseminated Intravascular Coagulation in Trauma-Induced Coagulopathy
-
Abstract Number: PB0799
A New Classification of Sepsis-Associated Disseminated Intravascular Coagulation (DIC) Based on Comprehensive Evaluation of Coagulation and Fibrinolysis
-
Abstract Number: PB0735
A New Genetic Alteration in Fibrinogen Gene with a Direful Phenotype: A Tie-in in a Newborn
-
Abstract Number: PB2229
A New Global Assay for Detection of Protein C Pathway-Associated Thrombophilia Using Thrombomodulin-Mediated Clot Waveform Analysis
-
Abstract Number: PB0326
A New Test Set up to Dose Factor VIII Ability to Bind Exogenous VWF
-
Abstract Number: PB2136
A Newly Developed Kit for High-Sensitivity Measurement of TF-Dependent Procoagulant Activity on Microvesicles Purified by High-Speed Centrifugation
-
Abstract Number: PB1144
A Next Generation Recombinant Factor VIII for Subcutaneous Hemophilia A Prophylaxis
-
Abstract Number: PB2301
A Non-invasive Diagnostic Work-up Is Safe and Efficient to Exclude Pulmonary Embolism in Low Risk Pregnant Women with Suspected Pulmonary Embolism: A Systematic Review and Meta-analysis
-
Abstract Number: LB/CO01.1
A Novel Adeno Associated Virus (AAV) Gene Therapy (FLT180a) Achieves Normal FIX Activity Levels in Severe Hemophilia B (HB) Patients (B-AMAZE Study)
-
Abstract Number: PB0223
A Novel Coagulation Factor VIII with Reduced Immunogenicity
-
Abstract Number: OC 05.2
A Novel Contact Pathway Inhibitor Improves Hemostasis and Maintains Circuit Patency in a Piglet Model of Pediatric ECMO
-
Abstract Number: PB1147
A Novel FVIIIa-Mimetic Bispecific Antibody, Mim8, Enhances FIXa Proteolytic Activity While Allowing for Efficient, Lipid-Dependent Assembly with FX
-
Abstract Number: PB1097
A Novel Human Factor VIII Variant Exhibits Increased Factor VIII Expression after AAV Gene Therapy in a Unique Hemophilia A Dog Model that is Tolerant to Human Factor VIII
-
Abstract Number: PB1599
A Novel Image-Based Chemical-Genetics Screen Identifies Inducers of Platelet Release from Immortalized Megakaryocytic Cell Lines, Enabling Clinical-Scale Production of Functional Platelets
-
Abstract Number: PB0410
A novel Interaction between Coagulation Factor XI and its Activated Form, FXIa, with the Complement Protein Properdin
-
Abstract Number: PB1677
A Novel Methodology to Study αIIbβ3 Interactions with Polymerizing Cross-linked Fibrin
-
Abstract Number: PB1434
A Novel Missense Mutations of the WASp Gene Cause a Familial X-linked Thrombocytopenia
-
Abstract Number: OC 14.1
A Novel Neutrophil Extracellular Traps (NETs) Assay Predicts DIC and Stratifies Patients with Sepsis for Anti-IL-8 Therapy
-
Abstract Number: PB0641
A Novel Point-of-Care Whole Blood Coagulation Assay to Screen for Hemostatic Defects
-
Abstract Number: PB0169
A Novel Prediction Platform to Enhance the Design of Therapeutic SERPINs
-
Abstract Number: PB0660
A Novel Quantitative Chromogenic Fibrinogen Assay Adaptable to Centralized Laboratory Analyzers
-
Abstract Number: PB0158
A Novel Rare C. – 39C>T Mutation in the PROS1 5’UTR Causes Protein S Deficiency by Creating a New Upstream Translation Initiation Codon and an Overlapping Open Reading frame
-
Abstract Number: PB1669
A Novel Reporter Mouse Line Enables in vivo Imaging of Intracellular Calcium Fluxes in Platelets
-
Abstract Number: PB0793
A Novel Therapeutic Approach for Acute Thrombo-hemorrhagic Disorders Evoked by Snake Venom: Potential of Rutin and Rutin Succinate
-
Abstract Number: PB1220
A Nurse Led Service Providing Safe and Effective Peri-Operative Anticoagulation
-
Abstract Number: PB0608
A Performance Evaluation of Chemiluminescent-Enzyme Immunoassays on a Routine Coagulation Analyser
-
Abstract Number: PB1806
A Potential Role for the FcγRIIa in Vinorelbine Induced Thrombocytopenia and Neutropenia
-
Abstract Number: PB2274
A Practical Comparison of a PE Diagnostic Approach: Is All Wells in the World?
-
Abstract Number: PB2357
A Prospective Observational Multicentre Study to Assess the Incidence of and Risk Factors for (T) Thrombosis (I) in Patients with (L) Lower (L) Limb (I) Injuries (R) Requiring (I) Immobilisation in Ireland (TILLIRI)
-
Abstract Number: PB0896
A Randomized Controlled Trial: Pharmacokinetic-Guided Dosing of Factor VIII Concentrate Versus Standard Replacement Therapy in Perioperative Hemophilia A Patients (OPTI-CLOT Trial)
-
Abstract Number: PB0957
A Randomized, Multicenter, Open-label, Phase III Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus No Prophylaxis in Persons with Hemophilia A in the Asia-Pacific region (HAVEN 5)
-
Abstract Number: PB0774
A Rare Case of Acquired Haemophilia A with Platelet Dysfunction Associated with Non Hodgkin Indolent Lymphoma
-
Abstract Number: PB1302
A Rare Case of Phlephlebitis; An Unusual Underlying Reason for Portal Venous Thrombosis
-
Abstract Number: PB0875
A Real-World Qualitative Analysis of the Burden of Hemophilia B and Patient Experiences with Prophylactic Nonacog Beta Pegol
-
Abstract Number: PB0093
A Recurrent Ischaemic Stroke Case with Type 1 von Willebrand Disease
-
Abstract Number: PB2255
A Retrospective Cohort Study on Splanchnic Vein Thrombosis
-
Abstract Number: PB2315
A Retrospective Study of Incidence of Venous Thromboembolism (VTE) and Prevalence of Risk Factors Associated with VTE in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
-
Abstract Number: PB1551
A Retrospective Study to Evaluate the Efficacy and Safety of a Plasma-Derived, von Willebrand Factor-Containing FVIII Concentrate, in Patients with Von Willebrand Disease (VWD) in Spain: Interim Analysis Results
-
Abstract Number: PB1311
A Rise in Plasma Coagulability During the First 3 Months Following Provoked Venous Thromboembolism is Associated with the Development of Post-Thrombotic Syndrome in Children and Young Adults: Analysis of the Kids-DOTT Multicenter Trial-Derived Biobank
-
Abstract Number: PB0224
A Sensitive and Specific Assay to Measure TF Activity in Cell-derived Extracellular Vesicles Based on Thrombin Generation
-
Abstract Number: PB1166
A Simple Algorithm to Identify Emicizumab Interference in Samples Received in the Clinical Coagulation Laboratory
-
Abstract Number: PB1053
A Simplified Health Education Program Improves Knowledge and Practices of Home Treatment in Hemophilia A Adolescents in a Developing Country
-
Abstract Number: PB2285
A Simplified Management Strategy for Suspected Pulmonary Embolism: External Validation of the YEARS Diagnostic Algorithm
-
Abstract Number: PB0953
A Single Center Data on Extended Half-Life Recombinant Factor VIII (FVIII:Fc) in Patients with Hemophilia A
-
Abstract Number: PB2481
A Single Centre Experience on the Use of Direct Oral Anticoagulants in People with Human Immunodeficiency Virus (HIV)
-
Abstract Number: PB2321
A Single-Centre Case Series of Venous Thromboembolic Disease
-
Abstract Number: PB0382
A Single-Domain Antibody that Exerts an Anticoagulant Effect Dependent on Protein S
-
Abstract Number: PB1062
A Snapshot of a Prospective, Non-interventional Study to Evaluate Routine Practice Prophylactic Treatment Schedules – NIS-Previq
-
Abstract Number: PB0595
A Strategy for the Prenatal Diagnosis for Fetus with Hemophilia A without Genetic Defects
-
Abstract Number: PB0312
A Strategy of Continued Antiplatelet Agents, Vitamin K Antagonists, and Direct Oral Anticoagulants throughout the Perioperative Period of Diabetic Foot Surgery in Patients Receiving Chronic Antithrombotic Therapy
-
Abstract Number: PB0052
A Study on Pressure Overload-Induced Cardiac Hypertrophy Model in Mice by Applying Transverse Aortic Constriction and O-Ring Ascending Aortic Banding Technique: A Comparative Analysis
-
Abstract Number: PB1369
A Subpopulation of ITP Patients Resembling Glanzmann Thrombasthenia Phenotype Revealed by Flow Cytometry Analysis of Platelet Intracellular Signalling
-
Abstract Number: PB2269
A Systematic Review and Meta-Analysis on Diagnostic Delay in Pulmonary Embolism
-
Abstract Number: PB0623
A Universal Quality Control Plasma for Anti-Xa and Anti-IIa Drugs
-
Abstract Number: PB1777
A Validated Model for the Diagnosis of Periprosthetic Joint Infection with Coagulation-related Markers: TGT and NETs
-
Abstract Number: PB1485
A Whole Blood Flow Cytometric Method for Diagnosis of Platelet Function Disorders
-
Abstract Number: PB0954
Abdominal Catastrophe in Hemophilic Patients: Towards Wise Decision Making
-
Abstract Number: PB2558
ABO Blood Groups and Inherited Thrombophilia in Women with Abortion
-
Abstract Number: PB0041
Absence of Protein Tyrosine Phosphatase-1B in Smooth Muscle Cells Promotes Perivascular Fibrosis: Role of Receptor Tyrosine Kinase Signaling
-
Abstract Number: PB1614
Accelerated Death of Wiskott-Aldrich Syndrome Megakaryocytes
-
Abstract Number: PB0586
Accuracy of Commercial Universal Calibrators for Measurement of Heparin and Low Molecular Weight Heparin
-
Abstract Number: OC 10.3
Accurate and Efficient Non-Invasive Strategy for Early Identification of Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism (InShape II Study)
-
Abstract Number: PB1754
Acetyl-CoA Carboxylase Inhibition Alters Tubulin Acetylation and Aggregation in Thrombin-stimulated Platelets
-
Abstract Number: PB1759
Acetylation of α-Tubulin by Aspirin and Histone Deacetylase 6 in Human Platelets
-
Abstract Number: PB1177
Achenbach Syndrome in a 19 Year-Old Girl: A Clinical Case
-
Abstract Number: PB1335
Achieving Clinically Relevant Platelet Count Response Thresholds with Avatrombopag (AVA) in Immune Thrombocytopenia (ITP)
-
Abstract Number: PB0475
Acquired Antithrombin III Deficiency Is a Risk Factor for Venous Thromboembolism after Severe Injury
-
Abstract Number: PB0773
Acquired Deficiency of Dependent Coagulation Factors of Vitamin K, at the Teaching Center: Experience In 10 Years
-
Abstract Number: PB1701
Acquired GPVI Deficiency Is a Biomarker for Early Diagnosis and Prognostic Assessment of Patients with Sepsis
-
Abstract Number: PB0162
Acquired Haemophilia Spanish Registry, First Five Years of Activity
-
Abstract Number: PB0795
Acquired Hemophilia A in Young Nulliparous Woman: A Case Report
-
Abstract Number: PB0780
Acquired Hemophilia in Argentina: A Multicentric Study
-
Abstract Number: PB1882
Acquired Thrombotic Thrombocytopenic Purpura: Key Findings of Patients from Southern Italy
-
Abstract Number: PB2295
Acquired Type II (IIb) Protein S Deficiency, Case Report
-
Abstract Number: PB1583
Acquired von-Willebrand-Disease (aVWD) in ECMO Patients: a 3-Year Cohort Study
-
Abstract Number: PB1785
Activated Factor XI Promotes Complement Activation by Neutralizing Complement Factor H
-
Abstract Number: OC 06.4
Activated Protein C Reverses the p21-Mediated Hyperglycemic Memory in Diabetic Nephropathy
-
Abstract Number: PB0381
Activated Protein-C up Regulates Microparticles Release from Ovarian Cancer Cell Line
-
Abstract Number: PB1111
Activated Prothrombin Complex Concentrates for the Management of Direct Oral Anticoagulant-Associated Bleeding Events and Pre-Operative Administration for Urgent Surgery: Hemostatic and Thrombotic Outcomes
-
Abstract Number: PB0154
Activated recombinant Factor VII (rFVIIa) Inhibitor in Iran: Immunogenicity is a Major Challenge through Treated Bleeds Covered with rFVIIa
-
Abstract Number: PB0249
Activation of Coagulation by 5.8S RNA
-
Abstract Number: PB2013
Activation of ERK Signaling Pathway by Plasma IgG in Venous Thromboembolism Patients without Antiphospholipid Antibodies
-
Abstract Number: PB0462
Active Thrombin and its Value: New Approach to Diagnosis of Thrombosis?
-
Abstract Number: PB1103
Activity Measurement of Factor IX Padua against the 4th International Standard for FIX, Plasma
-
Abstract Number: PB0394
Acute Deep Vein Thrombosis Is Associated with Increased Platelet Thrombin Generation and Increased Procoagulant Oxidised Phosphatidylethanolamine
-
Abstract Number: PB1820
Acute Exacerbations of COPD Induce a Prothrombotic State through Platelet-Monocyte Complexes, Endothelial Activation and Increased Thrombin Generation
-
Abstract Number: PB0113
Acute Leriche Syndrome in a 55-Year-Old Woman with Recurrent Central Pulmonary Embolism: A Case Report
-
Abstract Number: PB0360
ADAMTS-13/VWF as Biomarker for Portal Vein Thrombosis Development in Cirrhotic Patients: A Prospective Study
-
Abstract Number: OC 07.2
ADAMTS13 Conformation Is Closed in Acquired Thrombotic Thrombocytopenic Purpura in the Absence of Anti-ADAMTS13 Autoantibodies
-
Abstract Number: PB1429
Addition of Exogenous Platelet Factor 4 in the Heparin Induced Platelet Activation (HIPA) Assay for the Detection of Pathogenic Heparin-induced Thrombocytopenia Antibodies
-
Abstract Number: PB0227
Addition of Histone Deacetylase Inhibitors Increases Recombinant Factor V Expression in BHK Cells
-
Abstract Number: PB1093
Adenovirus Mediates Expression of Human Coagulation Factor IX Gene in Adipose-Derived Mesenchymal Stem Cells
-
Abstract Number: PB0368
Adhesive Properties of Plasma-Circulating and Platelet-Derived Microvesicles
-
Abstract Number: PB0479
Administration of Fibrinogen vs. Cryoprecipitate Stored out to 10 Days in Microfluidic Models of Coagulopathies in Hemorrhage
-
Abstract Number: PB1570
Adolescent Menorrhagia and Von Willebrand Disease
-
Abstract Number: PB0787
Advanced Principles of Prevention and Treatment of Preeclampsia in Women with Antiphospholipid Syndrome (APS) and MTHFR C677T Mutation
-
Abstract Number: PB0687
Advancing the Understanding and Significance of Genetic Testing Results in Hemostasis/Thrombosis
-
Abstract Number: PB0962
Adverse Event Reporting in Haemophilia A Patients with and without Inhibitors Treated with Emicizumab: A Report from the Co-morbidity Working Party of the UK Haemophilia Centres Doctors´ Organisation (UKHCDO)
-
Abstract Number: PB2189
Afibrinogenemia and Leiden FV Within the Same Family
-
Abstract Number: PB1199
Afibrinogenemia: Identification of a New Mutation in FGB
-
Abstract Number: PB0083
African American Women with Diabetes Undergoing Catheterization Represent Most Prothrombotic Subgroup: An Explanation for the Platinum Diversity Study Results?
-
Abstract Number: PB2015
Ageing Affects Neutrophils – Changes in Activation, DNA Release and Neutrophil Extracellular Formation of Neutrophil Subpopulations with Human Age
-
Abstract Number: PB0703
Algorithm for Detection of Procoagulant Samples with Elevated Prothrombin and Reduced Antithrombin by their Ability to Deplete Fluorogenic Thrombin Substrate
-
Abstract Number: PB0241
Allosteric Modulation of Exosite 1 Attenuates the Enhancing Effect of Polyphosphate on FXI Activation by Thrombin
-
Abstract Number: PB2012
Altered Coagulation Parameters and D-Dimer Measurements in Sepsis Are Useful in Scoring the Risk Stratification
-
Abstract Number: PB0668
Altered FIBTEM/Fibrinogen Correlation in Liver Transplant Patients Relative to Cardiac Surgery Patients
-
Abstract Number: PB2532
Alternative Complement Pathway Activation in the Severe Hypertensive Disorders of Pregnancy
-
Abstract Number: PB0239
Always Ask Relevant Questions to Patients Might Be They Tell You the Diagnosis
-
Abstract Number: PB2097
Amelioration of the Pathologic Changes in the Hepatocyte-Specific BRAFV600E Mutated Mice by Administration of Aspirin
-
Abstract Number: PB1700
An Activation-dependent Pathway Modulated by Dicer1 Neosynthesis and Down-regulating Platelet Reactivity Is Impaired in Diabetes
-
Abstract Number: PB1729
An Artificial Lipid Membrane Platform as an Approach to Study CLEC-2 Receptor Clustering
-
Abstract Number: PB2270
An Assessment of the Cost-Effectiveness of Whole-Leg Ultrasound Scans Compared to Proximal Leg Vein Ultrasound Scans in the Diagnosis of Acute Deep Vein Thrombosis
-
Abstract Number: PB2379
An Audit Examining Information Provided to Patients Regarding Venous Thromboembolism (VTE) at Discharge
-
Abstract Number: PB0481
An Audit of Fresh Frozen Plasma Transfusions: Justified or Not?
-
Abstract Number: PB1635
An Elevated Platelet Count Increases the Rate of Prothrombin Activation, but Not the Total Amount of Thrombin Formed
-
Abstract Number: PB0614
An Evaluation of the Assay Performance of the Antifactor Xa Assay for Rivaroxaban
-
Abstract Number: PB2469
An Evaluation of the Basis for Anti-Xa Testing in Patients on Low Molecular Weight Heparin and its Impact on Subsequent Management
-
Abstract Number: PB0626
An Evaluation of Treatment Monitoring in Patients with VWD Using a Chemiluminescent (VWF:GP1bR) Assay Compared to a Lyophilised Platelet Assay with Ristocetin (VWF:RCo)
-
Abstract Number: PB0556
An Improved Algorithm for the Detection of Lipemia as Interfering Substances on a Fully Automated Coagulation Analyzer
-
Abstract Number: OC 09.3
An Insight into Clinical Outcomes in Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study
-
Abstract Number: OC 09.2
An International Multicenter Study of Bevacizumab for Bleeding in Hereditary Hemorrhagic Telangiectasia (The InHIBIT-Bleed Study)
-
Abstract Number: PB0582
An International Study on the Interpretation of Test Results of the APTT Mixing Test
-
Abstract Number: PB1206
An Italian Survey on the Real-world Use of rFXIII (Catridecacog) in Patients with Factor XIII Deficiency
-
Abstract Number: PB2086
An observational Study of INR Control and Bleeding Events, According to European Society of Cardiology (ESC) Guidelines, in Non-valvular Atrial Fibrillation (NVAF) Stratified by Male and Female Sex
-
Abstract Number: PB0343
An Overview of Patients with Hemophilia A in China: Epidemiology, Disease Severity, and Treatment Strategies
-
Abstract Number: PB1947
An Unusual Case of Cerebral Cavernous Malformation Complicated with Consumptive Coagulopathy and Heightened Fibrinolysis
-
Abstract Number: PB0457
Analysis of Biomarkers of Hemostatic Dysregulation and Inflammation in Lymphoma Patients
-
Abstract Number: PB2300
Analysis of Hemodynamic and Hemocoagulation Changes in Mortality Structure in Polytrauma Patients
-
Abstract Number: PB0550
Analysis of Megathrombocytes as a New, Fast, and Low Cost Tool to Indicate Thrombosis and Predict Prognosis in Sickle Cell Disease
-
Abstract Number: PB2443
Analysis of Outcomes Following Inferior Vena Cava (IVC) Filter Placement in a Single Center Population
-
Abstract Number: PB0778
Analysis of Patients with Diagnosis of Adquired Haemophilia in a Third Level Hospital
-
Abstract Number: PB0630
Analysis of Platelet Functional Activity by Flow Cytometry: Reference Intervals and Cut-off Value for Evaluating the Efficiency of Antiplatelet Therapy
-
Abstract Number: PB2505
Analysis of Population Values in Pregnant Women
-
Abstract Number: PB0573
Analytical Performance Validation of the T-TAS 01 PL Assay
-
Abstract Number: PB0638
Analytical Validation of a Novel Whole Blood Coagulometer for NOAC Testing
-
Abstract Number: PB0348
Analytical Variability (CV) of One Stage Factor VIII Assay: A Quality Control (QC) Experience. Argentinian Group of Biochemists in Hemophilia
-
Abstract Number: PB0616
Analytical Verification of Automated Latex-Enhanced Particle Immunoturbidimetric D-Dimer Assays on Diferent Analytical Platforms and Comparability of Test Results
-
Abstract Number: PB1431
Anaphylactic Shock to Apixaban in a Patient Treated for Heparin-induced Thrombocytopenia (HIT)
-
Abstract Number: PB1119
Andexanet and Prothrombin Complex Concentrate Give Comparable Haemostatic Efficacy for Major Bleeding in Patients on Factor Xa Inhibitors
-
Abstract Number: PB0839
Animal Model Construction for Hemophilic Arthritis: Evaluation of Hemophilia Joint by Ultrasound Detection
-
Abstract Number: PB0124
Anti-Aggregant Effect of Butanolic Extract of Rubia Tinctorum on Platelets in vitro and ex vivo
-
Abstract Number: PB1784
Anti-complement Effect of Heparin in Stimulated Whole Blood
-
Abstract Number: PB0226
Anti-factor V Inhibitor after Liver Transplantation
-
Abstract Number: PB1796
Anti-Platelet Drug Ticagrelor Has a Direct Anticancer Activity
-
Abstract Number: PB1919
Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies Cause Lupus Anticoagulant by Interfering with Factor Xa-Mediated Factor V Activation
-
Abstract Number: PB0104
Antiaggregation Evaluation of Aspirin and Clopidogrel in Endovascular Treatment of Intracranial Aneurysms with Flow Diverter Stents
-
Abstract Number: PB1637
Antibodies Protect Platelets against Streptococcus Pneumoniae Toxin Pneumolysin
-
Abstract Number: PB0424
Anticoagulant Activity in Unclassified Bleeding Disorders
-
Abstract Number: PB0213
Anticoagulant Effect of Novel Nanoparticles Functionalized with Synthetic Piperazinone Derivatives as FXa Inhibitors
-
Abstract Number: PB0182
Anticoagulant Effects of Parenteral Sulodexide as Measured by Activated Clotting Time. Relevance to Dosing in Various Indications
-
Abstract Number: PB2074
Anticoagulant Management Strategies in Cancer Patients with Atrial Fibrillation in Daily Clinical Practice
-
Abstract Number: PB2442
Anticoagulant Therapy for Splanchnic Vein Thrombosis in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
-
Abstract Number: PB2254
Anticoagulant Therapy for Splanchnic Vein Thrombosis: A Systematic Review and Meta-Analysis
-
Abstract Number: PB2460
Anticoagulation Control with the Point-of-Care INR: A Retrospective Pre-/Post-analysis
-
Abstract Number: PB2517
Anticoagulation for Women with Mechanical Heart Valves during Pregnancy: A Survey
-
Abstract Number: PB2445
Anticoagulation in Cirrhosis: Thrombin Generation Assay vs Anti FXa Activity
-
Abstract Number: PB2055
Anticoagulation in Non-Valvular Atrial Fibrillation: Old or New Friends?
-
Abstract Number: PB2069
Anticoagulation Resumption After Intracerebral Hemorrhage in Two Cohorts of Patients Treated with Vitamin K Antagonists and Direct Oral Anticoagulants
-
Abstract Number: PB2154
Anticoagulation Therapy as Prevention of Cancer Relapce
-
Abstract Number: PB2159
Anticoagulation Therapy Management in Oncological Patients: Experience in a Center
-
Abstract Number: PB0166
Anticoagulation with the Novel, Small-molecule Factor XIa (fXIa) Antagonist, EP-7041, Prevents Oxygenator Clotting but Conserves Hemostasis in a Canine Extracorporeal Circulation (ECMO) Model
-
Abstract Number: PB0571
Antifactor Xa Levels vs. Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
-
Abstract Number: PB2168
Antimetastatic Profile of Bovine Intestinal Heparin and its Low Anticoagulant Activity Derivative
-
Abstract Number: PB1377
Antimicrobial Prophylaxis in Patients with Immune Thrombocytopenia Treated with Rituximab: A Retrospective Multicenter Analysis
-
Abstract Number: PB0029
Antioxidant Defense Gene Polymorphism in the Nenets Population
-
Abstract Number: PB1911
Antiphospholipid Antibodies “Multi-Positivity” in Women with Thromboembolism
-
Abstract Number: PB0011
Antiphospholipid Antibodies in Acute Myocardial Infarction
-
Abstract Number: PB2022
Antisense Oligonucleotide Targeting of Thrombopoietin Represents A Novel Platelet Depletion Method to Assess the Role of Platelets During Inflammation Resolution
-
Abstract Number: PB1312
Antithrombin Activity Level below 60% in Children Has Implications for Heparin (LMWH) Dosing
-
Abstract Number: PB2450
Antithrombin III Levels Immediately Following Acute Venous Thromboembolism
-
Abstract Number: PB0179
Antithrombotic Effects of a Novel Small Molecular Fxia Inhibitor BMS-986177/JNJ-70033093 in a Rabbit AV-Shunt Model of Thrombosis
-
Abstract Number: PB2367
Antithrombotic Offices of the Arkhangelsk Region Russia
-
Abstract Number: PB0144
Antithrombotic Properties of Carvedilol Shown in Two Independent Intravital Real Time Models of Thrombosis
-
Abstract Number: PB2452
Antithrombotic Stewardship: A Novel Approach to Appropriate Anticoagulant Prescription
-
Abstract Number: PB2543
Antithrombotic Therapy (Nadroparin Calcium) in the Prevention of Pregnancy Loss in aPL-Positive Women
-
Abstract Number: PB1469
Antithrombotic Therapy by Charged Nanoparticles
-
Abstract Number: PB2535
Antithrombotic Therapy for Pregnant Woman with Bland-White-Garland Syndrome and Prosthetic Mitral Valves
-
Abstract Number: PB1327
Antithyroid Treatment Improves Thrombocytopenia in a Young Patient with Graves´ Disease: A Case Report
-
Abstract Number: PB1965
Aortic Ring Angiogenesis Proceeds Normally Despite Minimal Tissue Factor Expression
-
Abstract Number: PB0853
APC: A New Suspect in the Hunt for a Mechanism of Bone Disease in Hemophilia
-
Abstract Number: PB2140
Apixaban Levels In Cancer-Associated Thrombosis In Low-Weight Individuals
-
Abstract Number: PB0606
Apixaban Plasma Concentration Estimation by Anti Xa Activity Assay Calibrated with Heparin Calibrators with 2 Different Reagent/Systems
-
Abstract Number: PB2399
Apixaban versus Heparin/Warfarin Treatment in Pulmonary Embolism: Results from the UK Apixaban Length-of-Stay Pulmonary Embolism – Hospital Admissions Study (ALPHA-PE)
-
Abstract Number: PB0361
APML: 2 Cases of Discordant Coagulation Results and ROTEM Testing
-
Abstract Number: PB2346
Apo(a) Polymorphisms rs3798220 and rs10455872 in a Brazilian Population of Deep Venous Thrombosis Pacients
-
Abstract Number: PB0072
Apolipoprotein A-IV Is an Endogenous Inhibitor of Thrombosis: The Roles of Polymorphisms in the Risk of Cardiovascular Disease
-
Abstract Number: PB0483
Apoptosis Inhibition during Cold Storage of Apheresis Platelet Concentrates Improves Cell Vitality without Affecting the Functionality
-
Abstract Number: PB1328
Apoptotic Markers May Help in Predicting the Disease Course of Pediatric Immune Thrombocytopenic Patients
-
Abstract Number: PB0585
Application of EP15A3 and EP15A2 Protocols to Verify the Performance of a Coagulometer in the Coagulation Laboratory of the National Institute of Respiratory Diseases in Mexico City
-
Abstract Number: PB1257
Application of the First Russian Biosimilar of Recombinant Clotting Factor VII in an Infant with Antenatal Cryptogenic Hepatitis and Bleeding Developed After Laparosopic Liver Biopsy
-
Abstract Number: PB2524
Approach to Venous Thromboembolism Risk in Women with Physical Disability in Pregnancy – Multidisciplinary Survey
-
Abstract Number: PB2485
Appropriateness of Direct Oral Anticoagulant Prescriptions in Emergency Department Outpatients with Acute Deep Vein Thrombosis
-
Abstract Number: PB0535
APTT Clot Waveform Analysis: A Tool in Prediction of Pre-Analytical Errors in Short APTT- Retrospective Analysis
-
Abstract Number: PB0702
APTT Mixing Studies in the Preoperative Setting
-
Abstract Number: PB0339
aPTT Reaction Curves Provide Important Additional Information in Hemophilia Patients
-
Abstract Number: PB2112
Are Patients with an Active Cancer and those with a History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding while on Anticoagulants?
-
Abstract Number: PB0219
Are the Plasma Levels Thresholds of DOAC Rationale and Appropriate for Clinical Decision-making? A Reappraisal Using Thrombin Generation Testing
-
Abstract Number: PB0244
Are Therapeutic Immunoglobulins Free from Factor XIa?
-
Abstract Number: PB2220
Are We Choosing Wisely? Heritable Thrombophilia (HT) Testing in a District General Hospital in the UK
-
Abstract Number: PB1296
Arterial Ischemic Stroke in Greek Infants, Children and Adolescents: a Single-Centre Experience
-
Abstract Number: PB0642
Artificial Intelligence to Identify Neutrophil Extracellular Traps in Peripehral Blood Smears
-
Abstract Number: PB1366
Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura
-
Abstract Number: PB1055
ASCVD Risk Score among Haemophilia Patients: Time to Formally Evaluate Cardiovascular Risk in People with Haemophilia
-
Abstract Number: PB2145
Aspects of Cancer-Related Venous Thrombosis in a cohort of 207 Tunisian Patients
-
Abstract Number: PB0060
Aspirin Antiplatelet Effects Are Associated with Body Weight
-
Abstract Number: PB1150
Assay of Emicizumab Using the Modified One-Stage Clotting Assay
-
Abstract Number: PB1260
Assessing Anticipatory Guidance Needs in Adolescents with Bleeding Disorders
-
Abstract Number: PB1688
Assessing Platelet Function in Large Cohorts, a Means to Donor Stratification
-
Abstract Number: PB0897
Assessing the Bleeding Phenotype in Non-Severe hemophilia by use of the ISTH Bleeding Assessment Tool (BAT)
-
Abstract Number: PB0605
Assessing the Effect of Freezing and Thawing of Samples for Anti-Factor Xa Testing for the Determination of Enoxaparin Activity
-
Abstract Number: PB0050
Assessing the Impact of Switching to the Tobacco Heating System on Cardiovascular Disease: Translating Basic Science into Clinical Benefit
-
Abstract Number: PB0534
Assessing the Quality of Interpretative Comments for Prolonged Activated Partial Thromboplastin Time and Mixing Tests
-
Abstract Number: PB1904
Assessment and Comparison of Acquired Activated Protein C Resistance with Two Thrombin Generation Methods, CAT and ST-Genesia, in APS and SLE Patients
-
Abstract Number: PB2057
Assessment and Predictors of Inappropriate Dose of Direct Oral Anticoagulants
-
Abstract Number: PB0279
Assessment of Coagulation Factor Levels in LVAD Patients Following Temporary Warfarin Reversal with 4F-PCC (KVAD Study)
-
Abstract Number: PB2545
Assessment of Endocan as a Marker for Preeclampsia and Its Clinical Forms
-
Abstract Number: PB0599
Assessment of ExpertCor, a New Set of Frozen Plasmas for Assay Comparability Studies
-
Abstract Number: PB2188
Assessment of Fibrinolysis Markers in Patients with Lower Limb Deep Venous Thrombosis: A Prospective Case-control Study
-
Abstract Number: PB0236
Assessment of Four Factor Prothrombin Complex Concentrate (4F-PCC) Usage in Emergency Department Patients: A Single Center Experience
-
Abstract Number: PB0712
Assessment of in vitro Effects of Direct Thrombin Inhibitors on Activation of Coagulation Factor XIII through Enzyme Kinetics in the Synthetic Substrate-Based Assay
-
Abstract Number: PB1481
Assessment of Platelet Function after Shear Stress Simulation Using an ex vivo Model for Extracorporeal Circulation
-
Abstract Number: PB2561
Assessment of Post-partum Haemorrhage Risk among Women with Thrombocytopenia: A Cohort Study
-
Abstract Number: PB2214
Assessment of Radiological Signs of Chronic Thromboembolic Pulmonary Hypertension on CTPAs Performed for Acute Pulmonary Embolism Leads to Earlier Diagnosis of CTEPH
-
Abstract Number: PB0609
Assessment of the CN-6000; a Novel, High-Speed Coagulation Analyser, Utilising Coagulation, Chromogenic, Immuno-Turdibimetric and Light Transmission Aggregation Technologies
-
Abstract Number: PB0303
Assessment of the Difference Between EXTEM and FIBTEM Amplitudes (PLTEM) and Their Correlation with Platelet Count (PLT), and the Effect of Fibrinogen and Hematocrit (HTC) in Cardiovascular Surgery (CVS)
-
Abstract Number: PB1408
Assessment of the Hemostatic System by Total Thrombus-formation Analysis System (T-TAS) in Patients with Chronic Coronary Syndromes
-
Abstract Number: PB2121
Assessment of the Ottawa Score in the Prediction of Recurrent Venous Thromboembolism in Patients Treated for Lymphoma
-
Abstract Number: PB1653
Assessment of Thrombus Formation under Flow-Conditions in Essential Thrombocythemia/ Polycythemia Vera
-
Abstract Number: PB1109
Assessment of Vector Integration of AAV5-hFIX in Mice and Non-human Primates Indicates No Association with Tumorigenic Risk
-
Abstract Number: PB1256
Assessment of Vitamin K Level in Newborn Presenting with Bleeding in Population of Rural Sindh, Pakistan
-
Abstract Number: PB1012
Association Between Aging and Health Status in Persons Leaving with Hemophilia and Controls Without a Bleeding Disorder – Insights from the PROBE Study
-
Abstract Number: PB2461
Association Between Index VTE Event and 12-Months Outcomes for Patients in Routine Clinical Practice Enrolled in the ETNA-VTE-Europe Registry
-
Abstract Number: OC 10.1
Association between Initial and Residual Pulmonary Vascular Obstruction and Venous Thromboembolism Recurrence, a Pooled Analysis
-
Abstract Number: PB1056
Association between Platelet Glycoprotein Common SNVs and Bleeding Severity in Haemophilia Patients
-
Abstract Number: PB0825
Association of Adherence and Bleeding Frequency among Severe Hemophilia A Patients on Prophylactic Factor VIII
-
Abstract Number: PB2080
Association of Body Mass Index (BMI) with Bleeding Events in Patients Taking Oral Anticoagulation for Atrial Fibrillation (AF) or Venous Thromboembolism (VTE)
-
Abstract Number: PB2060
Association of Clinical Risk Factors and Biomarkers with Thromboembolism, Major Bleeding, and All-Cause Death in Patients with Atrial Fibrillation in a Tertiary Care Setting
-
Abstract Number: PB1515
Association of Genetic Variability in Selected Genes in Patients with Deep Vein Thrombosis and Platelet Hyperaggregability
-
Abstract Number: PB0028
Association of MMP-12 and SDF1 with Symptomatic and Asymptomatic Atherosclerosis
-
Abstract Number: PB1885
Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)
-
Abstract Number: PB1621
Association of Platelet Derived – Microparticles and Endothelia Dysfunction in NVAF Patients Undertaking PCI
-
Abstract Number: PB2251
Association of Portal Vein Thrombosis and Clinical Outcomes in Cirrhotic Patients: A Nested Case-Control Study
-
Abstract Number: PB2333
Association of Surgical and Medical Hospitalizations with Venous Thromboembolism (VTE) in a Primary Care Population
-
Abstract Number: PB0943
Associations between Physical Activity Levels and Bleeding Frequency in People with Mild, Moderate, and Severe Hemophilia A (HA): A Preliminary Analysis of the CHESS II Study
-
Abstract Number: PB1984
Astrocytes Are Central Contributors in Restoration of the Blood Brain Barrier via Transcriptional Upregulation of Key Gap Junction Proteins between Endothelial Cells
-
Abstract Number: PB1266
Asymptomatic Catheter Related Thrombosis in Neonates: The Role of Thrombophilia Testing
-
Abstract Number: PB1018
ATHN 7: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Hemophilia-Demographics and Preliminary Results
-
Abstract Number: PB1331
Atorvastatin Restores the Imbalance of CD4+ T cells in Immune Thrombocytopenia via Ras/MEK/ERK and mTOR/PI3K/AKT Pathways
-
Abstract Number: PB2088
Atrial Fibrillation Treated with Warfarin at an Academic Medical Center: The Potential Impact of Direct Oral Anticoagulants on Future Management
-
Abstract Number: PB1605
Autoantibody Mediated Changes in Megakaryocytes Glycan Pattern: Potential Impact on Thrombopoiesis in Immune Thrombocytopenia
-
Abstract Number: PB0782
Autoimmune Acquired Factor XIII Deficiency: A Case Report
-
Abstract Number: PB1414
Autoimmune Heparin-Induced Thrombocytopenia Successfully Treated using Direct Oral Anticoagulant and Intra-Venous Immunoglobulin
-
Abstract Number: PB1862
Automated Chemiluminescent ADAMTS13 Activity Immunoassay for Thrombotic Thrombocytopenic Purpura Diagnosis and Follow-up
ISTH 2020 Congress
July 12-14, 2020. Virtual Congress.